Pro-inflammatory complement activation by the Aβ peptide of Alzheimer's disease is biologically significant and can be blocked by vaccinia virus complement control protein

Neurobiology of Aging

Volumn 19, Issue 6, 1998, Pages 619-627

  Daly IV, James ^a   Kotwal, Girish J ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

A ; Alzheimer's disease; Complement; Inflammatory response; Vaccinia virus complement control protein (VCP)

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT MEMBRANE ATTACK COMPLEX; UNCLASSIFIED DRUG; VACCINIA VIRUS COMPLEMENT CONTROL PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPLEMENT ACTIVATION; CONNECTIVE TISSUE; CONTROLLED STUDY; INFLAMMATORY CELL; MOUSE; NONHUMAN; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VACCINIA VIRUS;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BASE SEQUENCE; CHEMOTACTIC FACTORS; COMPLEMENT ACTIVATION; COMPLEMENT INACTIVATOR PROTEINS; COMPLEMENT MEMBRANE ATTACK COMPLEX; DOWN-REGULATION; HUMANS; MICE; PROTEIN BIOSYNTHESIS; RECOMBINATION, GENETIC; TRANSCRIPTION, GENETIC; VIRAL PROTEINS;

EID: 0032465459     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(98)00100-6     Document Type: Article

References (34)

1. 1. Adams, G.; Kuntz, S.; Rabalais, G.; Bratcher, D.; Tamburro, C.H.; Kotwal, G.J. Natural recovery from acute hepatitis C virus infection by agammaglobulinemic twin children. Pediatr. Infect. Dis. J. 16:533-534; 1997.
2. 2. Bradt, B. M. Kolb, W. P.; Cooper, N. R. Complement-dependent proinflammatory properties of the Alzheimer's disease beta-peptide. J. Exp. Med. 188:431-438; 1998.
3. 3. Breitner, J. C. Welsh, K. A.; Helms, M. J.; Gaskell, P. C.; Gau, B. A.; Roses, A. D.; Pericak-Vance, M. A.; Saunders, A. M. Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol. Aging 16:523-530; 1995.
4. 4. Cotman, C. W. Tenner, A. J.; Cummings, B. J. Beta-amyloid converts an acute phase injury response to chronic injury responses. Neurobiol. Aging 17:723-731; 1996.
5. 5. Cribbs, D. H. Velazquez, P.; Soreghan, B.; Glabe, C. G.; Tenner, A. J. Complement activation by cross-linked truncated and chimeric full-length beta-amyloid. Neuroreport 8:3457-3462; 1997.
6. 6. Daly, J. Kotwal, G. J. Immunobiology of the progressive chronic neurodegeneration of Alzheimer's disease (AD): Mounting evidence for the pivotal role of the inflammatory response. Immunologist 5:157-165; 1997.
7. 7. Daly, J. Lahiri, D. K.; Justus, D. E.; Kotwal, G. J. Detection of the membrane-retained carboxy-terminal tail containing polypeptides of the amyloid precursor protein in neural cells from Alzheimer's disease brain. Life Sci. 63:2121-2131; 1998.
8. 8. Elkabes, S. DiCicco Bloom, E. M.; Black, I. B.; Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function. J. Neurosci. 16:2508-2521; 1996.
9. 9. Glenner, G. G.; Wong, C. W. Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 122:1131-1135; 1984.
10. 10. Jiang, H. Burdick, D.; Glabe, C. G.; Cotman, C. W.; Tenner, A. J. beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. J. Immunol. 152:5050-5059; 1994.
11. 12. Kotwal, G. J. Interaction of microorganisms with the immune system. J. Leukoc. Biol. 62:415-429; 1997.
12. 13. Kotwal, G. J. Isaacs, S. N.; McKenzie, R.; Frank, M. M.; Moss, B. Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science 250:827-830; 1990.
13. 14. Kotwal, G. J., Miller, C. G.; Justus, D. E. The inflammation modulatory protein (IMP) of cowpox virus drastically diminishes the tissue damage by down-regulating cellular infiltration resulting from complement activation. Mol. Cell. Biochem. 185:39-46; 1998.
14. 15. Kotwal, G. J. Moss, B. Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins. Nature 335:176-178; 1988.
15. 16. Mackenzie, I. R. Munoz, D.G. Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging. Neurology 50:986-990; 1998.
16. 17. Maniatis, T. Fritsch, E. F.; Sambrook, J. Analysis of recombinant DNA clones. In: Molecular Cloning: A Laboratory Manual. New York: Cold Spring Harbor Press; 1984:363.
17. 18. Mann, D. M. A. Iwatsubo, T.; Fukumoto, H.; Ihara, Y.; Odaka, A.; Suzuki, N. Microglial cells and amyloid β deposition: Association with Ab40-containing plaques. Acta Neuropathol 90:472-477; 1995.
18. 19. McGeer, P. L. Akiyama, H.; Kawamata, T.; Yamada, T.; Walker, D.G.; Ishii, T. Immunohistochemical localization of beta-amyloid precursor protein sequences in Alzheimer and normal brain tissue by light and electron microscopy. J. Neurosci. Res. 31:428-442; 1992.
19. 20. McGeer, P. L. Schulzer, M.; McGeer, E. G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies. Neurology 47:425-432; 1996.
20. 21. McKenzie, R. Kotwal, G. J.; Moss, B.; Hammer, C. H.; Frank, M. M. Regulation of complement activity by vaccinia virus complement-control protein. J. Infect. Dis. 166:1245-1250.
21. 22. Meda, J., Cassatella, M. A.; Szendrei, G. I.; Otvos, J. L.; Baron, P.; Villalba, M.; Ferrari, D.; Rossi, F. Activation of microglial cells by b-amyloid protein and interferon-gamma. Nature 374:647-650; 1995.
22. 23. Miller, C. G. Shchelkunov, S. N.; Kotwal, G. J. The cowpox virus-encoded homolog of the vaccinia virus complement control protein is an inflammation modulatory protein. Virology 229:126-133; 1997.
23. 24. Moss, B. Elroy-Stein, O.; Mizukami, T.; Alexander, W. A.; Fuerst, T. R. Product review. New mammalian expression vectors. Nature 348:91-92; 1990.
24. 25. Paresce, D. M. Ghosh, R. N.; Maxfield, F. R. Microglial cells internalize aggregates of the Alzheimer's disease amyloid β-protein via a savenger receptor. Neuron 17:553-565; 1996.
25. 26. Sanger, F. Nicklen, S.; Coulson, A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:5463-5467; 1977.
26. 27. Soto, C. Kindy, M. S.; Baumann, M.; Frangione, B. Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation. Biochem. Biophys. Res. Commun. 226:672-680; 1996.
27. 28. Southern, E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:503-517; 1975.
28. 29. Tanzi, R. E.; St. George-Hyslop, P. H.; Haines, J. L.; Polinsky, R. J.; Nee, L.; Foucin, J. F.; Neve, R. L; McClatchey, A. I.; Conneally, P. M.; Gusella, J. F. The genetic defect in familial Alzheimer's Disease is not tightly linked to the amyloid beta-protein gene. Nature 329:156-157; 1987.
29. 30. Velazquez, P.; Cribbs, D. H.; Poulos, T. L.; Tenner, A. J. Aspartate residue 7 in amyloid beta-protein is critical for classical complement pathway activation: implications for Alzheimer's disease pathogenesis. Nat. Med. 3:77-79; 1997.
30. 31. Verbeek, M. M.; Ruiter, D. J.; De, W.R. The role of amyloid in the pathogenesis of Alzheimer's disease. Biol. Chem. 378:937-950; 1997.
31. 32. Webster, S.; Bradt, B.; Rogers, J.; Cooper, N. Aggregation state-dependent activation of the classical complement pathway by the amyloid beta peptide. J. Neurochem. 69:388-398; 1997.
32. 33. Webster, S.; Glabe, C.; Rogers, J. Multivalent binding of complement protein C1Q to the amyloid beta-peptide (A beta) promotes the nucleation phase of A beta aggregation. Biochem. Biophys. Res. Commun. 217:869-875; 1995.
33. 34. Webster, S.; Lue, L.F.; Brachova, L.; Tenner, A.J.; McGeer, P.L.; Terai, K.; Walker, D.G.; Bradt, B.; Cooper, N.R.; Rogers, J. Molecular and cellular characterization of the mebrane attack complex, C5b-9, in Alzheimer's disease. Neurobiol. Aging 18:415-421; 1997.
34. 35. Yan, S. D.; Fu, J.; Soto, C.; Chen, X.; Zhu, H.; Al-Mohanna, F.; Collison, K.; Zhu, A.; Stern, E.; Saido, T.; Tohyama, M.; Ogawa, S.; Roher, A.; Stern, D. An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease. Nature 389:689-695; 1997.